Flexbumin 20% Injection is a medication that contains Human Albumin as its active ingredient. It is used to treat hypoalbuminemia, or low blood protein levels, and to replace plasma volume.

Brand Namee: Flexbumin

Composition: Human Albumin

Mechanism of Action:

An essential protein called albumin aids in the maintenance of the oncotic pressure in blood vessels, preventing fluids from leaking into surrounding tissues and staying in the bloodstream. Especially in cases of shock or significant blood loss, flexbumin promotes tissue perfusion and blood volume.

Uses:

• Plasma volume expansion
• Hypoalbuminemia
• Cardiac Surgery & Dialysis

Dosage and Administration:

Given as an intravenous infusion. Dosage is depends on the patient's clinical condition, the severity of blood loss, or the extent of hypoalbuminemia. It is usually determined by the healthcare provider.

Side Effects:

• Fever
• Chills
• Rash
• Nausea
• Vomiting
• Shortness of breath

Safety Advise:

Kidney  

Patients with renal problems should take flexbumin 20% Infusion with caution. It could be necessary to modify the dosage of Flexbumin 20% Infusion. Kindly speak with your healthcare provider.

Liver  

Patients with liver problems should take flexbumin 20% Infusion with caution. It could be necessary to modify the dosage of Flexbumin 20% Infusion. Kindly speak with your healthcare provider.

Pregnancy  

Inform your healthcare provider before beginning the Flexbumin 20% injection 100ml treatment if you are expecting a child, are currently pregnant, or suspect a pregnancy. 

Breast Feeding  

Consult your healthcare provider before beginning Flexbumin 20% injectable 100ml treatment if you are nursing.

Alcohol  

It is unknown if drinking alcohol is safe when using a 100ml Flexbumin 20% injectable. Kindly speak with your healthcare provider.

Driving  

If your blood sugar level is too high or too low, it could damage your ability to drive. If you experience these symptoms, don't drive.

Storage:

Store at controlled room temperature and avoid freezing. Keep it out of direct sunlight.

References:

1.      Rozga J, Piątek T, Małkowski P. Human albumin: old, new, and emerging applications. Ann Transplant. 2013 May 10;18(1):205-17.

2.      Reviewers CI. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ: British Medical Journal. 1998 Jul 25:235-40.

3.    Bernardi M, Ricci CS, Zaccherini G. Role of human albumin in the management of complications of liver cirrhosis. Journal of clinical and experimental hepatology. 2014 Dec 1;4(4):302-11.

4.      Melia D, Post B. Human albumin solutions in intensive care: A review. Journal of the Intensive Care Society. 2021 Aug;22(3):248-54.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Baxalta Biosciences India Private Limited

Address: 6th Floor, Tower C, Building No. 8, DLF Cyber City, DLF Phase II Gurgaon Gurgaon HR 122001 IN

Country of origin: India